Our Solutions

newsletter

NEWSLETTER

  • Newsletter

    January 2015

    Jan 1, 2015

    The Algorithme Pharma team provides full bioanalytical support for Large Molecules through all phases of clinical development, including as part of regulated studies.

    The Algorithme Pharma team provides full bioanalytical support for Large Molecules through all phases of clinical development, including as part of regulated studies.

  • Newsletter

    Vince & Associates Clinical Research - Newsletter January 2015

    Jan 1, 2015

    Vince & Associates’ Stellar Regulatory History, Pharmacology Unit Expansion, Joins The Cardiac Safety Research Consortium, Qualified as Early Phase Provider for Clinical Evaluation of Thorough QT and Upcoming Presentations.

  • Newsletter

    November 2014

    Nov 1, 2014

    The impact of new partial AUC parameters for evaluating the bioequivalence of prolonged-release formulations, Thank you to everyone who joined us at the AAPS Annual Meeting in San Diego and Don't miss the 7th EBF Open Symposium!

  • Newsletter

    October 2014

    Oct 1, 2014

    Development and Validation of an ELISA for the Determination of AB-16B5 in Rat Serum, AAPS Annual Meeting, San Diego, Webinar — Impaired Renal Function Clinical Trials: Early Phase Planning to Minimize Risks and Accelerate Drug Development and 7th Open Symposium of EBF.

  • Newsletter

    Vince & Associates Clinical Research - Newsletter September 2014

    Sep 1, 2014

    Vince & Associates Clinical Research Awarded $5 Million FDA Contract to Conduct Clinical Studies, provides Platinum Sponsorship for the 6th Annual Pain Therapeutics Summit and CWWeekly’s semi-monthly company profile feature.

  • Newsletter

    September 2014

    Sep 1, 2014

    Biologics & Biosimilars: Key Considerations & Strategies in Early Stage Development and Overcoming the Bioanalysis Challenges of Biosimilars: Rituximab Case Study.

  • Newsletter

    August 2014

    Aug 1, 2014

    Improving Patient Recruitment for Early Phase Clinical Trials, Customizable First-In-Human Trial Gantt Chart and Bioanalysis Journal: Choosing the appropriate matrix to perform a scientifically meaningful lipemic plasma test in bioanalytical method validation.

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.